Elsevier

The Lancet

Volume 314, Issues 8156–8157, 29 December 1979, Page 1361
The Lancet

Letters to the Editor
MELATONIN/CORTISOL RATIO IN DEPRESSION

https://doi.org/10.1016/S0140-6736(79)92837-XGet rights and content

References (4)

There are more references available in the full text version of this article.

Cited by (113)

  • Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment

    2022, Behavioural Brain Research
    Citation Excerpt :

    Still, it has recently been shown that the phase angle between cortisol acrophase and dim-light melatonin onset (20 pg/ml) appears to differentiate healthy from depression, but additional studies with larger sample sizes deserve intensive investigation [59]. Consistent with that, plenty of evidence considered the melatonin/cortisol ratio as a significant criterion for distinguishing different types of depression and assessing the severity of depression [60]. In a double-blind study design, it was demonstrated that CRH, which is thought to be involved in HPA abnormalities in depressed patients, inhibited dramatically melatonin secretion [61].

  • An historical view of the pineal gland and mental disorders

    2011, Journal of Clinical Neuroscience
    Citation Excerpt :

    In this way, Anton-Tay et al.75 suggested that this hormone might have an antidepressive effect, an argument reinforced by the observation of the euphoric effect caused by melatonin following administration to healthy volunteers. Continuing with this research line, at the end of the 1970s, Wetterberg et al.76 found a reduction in the plasma levels of melatonin in depressive subjects and a specific reduction of night-time values in patients with suicidal ideas, as well as normalization following spontaneous recovery or after antidepressant treatment, while Mendlewicz et al.77 described the rhythms for the synthesis of melatonin in depressive patients, highlighting the absence of the nocturnal peak in melatonin characteristic of normal subjects (Fig. 4). The group of Lennart Wetterberg et al. in Stockholm has proposed a hypothesis known as “low melatonin syndrome”, whereby a low secretion of melatonin would constitute a biological marker for greater susceptibility to suffer a depressive disorder.76

View all citing articles on Scopus
View full text